(READ) FDA issues death warning on new cancer drug approved through “accelerated” process
The FDA has issued a safety alert on Pepaxto, a cancer drug approved under an accelerated process to treat multiple myeloma. The drug is called melphalan flufenamide. According to the FDA, Pepaxto causes an increased risk of death. Read the full FDA information below: [7/28/2021] FDA is alerting patients and health care professionals that a clinical […]
Continue reading (READ) FDA issues death warning on new cancer drug approved through “accelerated” process on sharylattkisson.com.
